IP Verse

Nucleic Acid Vaccines - EP4023249

EP4023249

MODERNA
Application Number
EP21195046A
Filing Date
Apr 23, 2015
Status
Granted And Under Opposition
Sep 6, 2024
Grant Date
Oct 9, 2024
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3394030B2
EP4108671B1
EP3981437B1

Bibliography

The patent EP4023249B1 was granted to Moderna on Oct 9, 2024 following the initial filing on Apr 23, 2015 under the application number EP21195046A . The current legal status of the patent is Granted And Under Opposition.

Patent Summary

Patent Family New

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

BIONTECHJul 9, 2025ADMISSIBLE
PFIZERJul 4, 2025ADMISSIBLE
SANOFIMar 3, 2025ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents